Supernus, Puma Among 5 Big Biotech Stock Winners, Losers Monday | Stock News & Stock Market Analysis - IBD
With 53% institutional ownership, Puma Biotechnology, Inc. (NASDAQ:PBYI) is a favorite amongst the big guns | Nasdaq
Why Puma Biotechnology, Applied Optoelectronics, and Ferroglobe Jumped Today | The Motley Fool
PBYI | Puma Biotechnology Inc. Stock Overview (U.S.: Nasdaq) | Barron's
Puma Biotechnology (PBYI) Q1 Earnings: Stock To Disappoint? | Investing.com
Video Puma Biotechnology Soars on Breast Cancer Drug Results - ABC News
Why Puma Biotechnology, Inc. Stock Crashed 37% in March | The Motley Fool
PUMA BIOTECHNOLOGY, INC. : PBYI Stock Price | US74587V1070 | MarketScreener
Why Puma Biotechnology Is Soaring Today | The Motley Fool
Puma Biotech News, Puma Biotech Quote, PBYI Quote - StreetInsider.com
Why Puma Biotech Could Get Acquired Between July to September of This Year | BioSpace
Puma Biotechnology: A Speculative Investment At A Discount (NASDAQ:PBYI) | Seeking Alpha
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) | citybiz
News Release
Puma Biotechnology Inc
Why Puma Biotechnology Shares Dropped 17.7% This Week | The Motley Fool
Puma Biotechnology up 15% after quarterly earnings beats (NASDAQ:PBYI) | Seeking Alpha
Puma Biotechnology Announces $10 Million Private Placement | Business Wire
Puma Biotechnology: Risky Investment (NASDAQ:PBYI) | Seeking Alpha
Puma Biotechnology Secures $125 Million Note Purchase by Athyrium Capital | Business Wire
Puma Biotechnology | $PBYI Stock | Shares Climb Up as Company Announced FDA Approval for NERLYNX - Warrior Trading News
Is Puma Biotechnology (PBYI) Stock a Solid Choice Right Now?
Puma Biotechnology Inc. (PBYI) Stock Price, Quote & News - Stock Analysis
